IIPR

A month has gone by since the last earnings report for Innovative Industrial Properties (IIPR). Shares have lost about 6.9% in that time frame, underperforming the S&P 500. Will the recent negative trend continue leading up to its next earnings release, or is Innovative Industrial Properties due for a breakout? Well, first let's take a quick look at its latest earnings report in order to get a better handle on the recent catalysts for Innovative Industrial Properties, Inc. before we dive into how investors and analysts have reacted as of late. Innovative Industrial reported second-quarter 2026 AFFO of $1.83 per share, up 7% year over year and beating the Zacks Consensus Estimate of $1.78 by 2.8%. Total revenues rose 0.7% to $63.31 million but missed the consensus mark of $66.47 million by 4.8%. New leases and contractual rent escalations supported the top line, while property sales, tenant defaults and lease terminations offset much of the benefit. The operating portfolio was 95.8% leased as of June 30, 2026. Rental revenues, including tenant reimbursements, were $62.89 million compared with $62.87 million a year earlier. Other revenues increased to $0.43 million from $0.03 million, leaving the overall top-line gain modest despite leasing activity. Through June, Innovative Industrial executed five leases covering 389,000 square feet, representing 5% of total portfolio square footage. At quarter-end, the portfolio comprised 108 properties across 19 states and 8.4 million rentable square feet. Weighted-average lease length was 11.9 years, while total invested capital stood at $2.4 billion. Interest and other income jumped to $10.75 million from $1.57 million a year earlier. The increase primarily reflected $8.50 million of interest and dividend income from the company’s financial investments in IQHQ, along with interest on the seller-financed note tied to the Perth, NY, property sale. Innovative Industrial fully funded its $270 million IQHQ commitment by June 30, 2026. The investment consists of a $100 million revolving credit facility carrying a 13.5% yield and $170 million of preferred equity carrying a 15% yield. The company’s annualized base rent and income from loans and securities totaled $324.69 million at quarter-end. Cannabis represented 87.6% of the mix, life sciences 12.2% and other sources 0.2%. Property expenses increased 4.8% year over year to $7.20 million, while general and administrative expenses declined 10.5% to $7.72 million. Interest expense climbed 87.8% to $8.35 million from $4.44 million. On a GAAP basis, net income attributable to common stockholders rose 61.7% to $40.67 million, or $1.36 per share. Results included an $11.85 million net gain on real estate sales, which is excluded from FFO. The quarter included a $16.70 million gain on the sale of the Perth property and a $4.90 million loss on the sale of a land parcel in San Marcos, TX. Gross proceeds from the two transactions totaled $91.77 million. Payments received from defaulted tenants PharmaCann and 4Front totaled $1.90 million in the second quarter, down from $3.47 million in the first quarter. PharmaCann surrendered its Ohio property in April, and the company immediately entered into a 58,000-square-foot full-building lease with Curaleaf at that location. For 4Front, Innovative Industrial reached tentative arrangements with prospective tenants for four assets in Illinois, Washington and Massachusetts. The arrangements remain subject to contingencies, including license-transfer approvals, and are expected to become effective after receivership proceedings conclude by year-end 2026 or early 2027. PharmaCann remained in possession of the New York and Pennsylvania properties with IIPR’s consent while working toward transfers of the existing licenses to new tenants. The company had resolved all pending litigation with PharmaCann related to its prior lease defaults. Innovative Industrial ended June with $204.7 million of cash and cash equivalents and total liquidity of $299.7 million. Net debt to total gross assets was 14.2%, while net debt to adjusted EBITDA stood at 1.7 times. During the quarter, the company completed a $402.5 million offering of 6% exchangeable senior notes due 2029 and fully repaid $291 million of 5.50% unsecured notes due 2026. It also repurchased $89.0 million of common stock, while issuing common and preferred shares through its ATM programs for net proceeds of $34.8 million and $20.9 million, respectively. In the past month, investors have witnessed a downward trend in fresh estimates. At this time, Innovative Industrial Properties has a poor Growth Score of F, however its Momentum Score is doing a bit better with a D. However, the stock was allocated a grade of B on the value side, putting it in the second quintile for value investors. Overall, the stock has an aggregate VGM Score of D. If you aren't focused on one strategy, this score is the one you should be interested in. Estimates have been broadly trending downward for the stock, and the magnitude of these revisions indicates a downward shift. Interestingly, Innovative Industrial Properties has a Zacks Rank #3 (Hold). We expect an in-line return from the stock in the next few months. Innovative Industrial Properties is part of the Zacks REIT and Equity Trust - Other industry. Over the past month, Welltower (WELL), a stock from the same industry, has gained 3.8%. The company reported its results for the quarter ended June 2026 more than a month ago. Welltower reported revenues of $3.54 billion in the last reported quarter, representing a year-over-year change of +39.1%. EPS of $0.61 for the same period compares with $1.28 a year ago. For the current quarter, Welltower is expected to post earnings of $1.64 per share, indicating a change of +22.4% from the year-ago quarter. The Zacks Consensus Estimate has changed +0.6% over the last 30 days. The overall direction and magnitude of estimate revisions translate into a Zacks Rank #3 (Hold) for Welltower. Also, the stock has a VGM Score of D. Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report Innovative Industrial Properties, Inc. (IIPR) : Free Stock Analysis Report Welltower Inc. (WELL) : Free Stock Analysis Report This article originally published on Zacks Investment Research (zacks.com). Zacks Investment Research

Interested in Innovative Industrial Properties, Inc.? Here are five stocks we like better. Second-quarter performance weakened: Revenue fell to $63.3 million and adjusted funds from operations declined to $53 million, primarily because of reduced payments from defaulted tenants. Leasing and asset recycling advanced: IIPR reported approximately 877,000 square feet of leasing activity, expects to regain two Florida properties from defaulted tenant Parallel, and completed an $88.5 million New York property sale to recycle capital. Capital position and diversification strengthened: The company fully funded its $270 million IQHQ life sciences commitment, completed nearly $150 million in secured financings, ended the quarter with $300 million of liquidity, and highlighted potential benefits from cannabis rescheduling and broader industry access to capital markets. This 4/20, Wall Street Is Betting on More Than Marijuana Innovative Industrial Properties (NYSE:IIPR) reported second-quarter revenue of $63.3 million and adjusted funds from operations of $53 million, or $1.83 per diluted share, as the cannabis-focused real estate investment trust advanced leasing efforts, completed a major life sciences investment commitment and refinanced its balance sheet. Revenue declined from $69 million in the first quarter, while AFFO decreased from $53.4 million, or $1.88 per diluted share. Chief Financial Officer David Smith said the declines were primarily driven by reduced payments from certain defaulted tenants, partially offset by contractual rent escalations and additional leasing revenue. → SpaceX’s First Earnings Report Could Decide Whether Shorts or Bulls Have Control The only 2 cannabis companies you need to own The company said it executed new leases totaling approximately 389,000 square feet across five properties in California, Illinois and Ohio during the first half of 2026. That activity is in addition to 488,000 square feet of agreements involving four properties formerly leased to 4Front Ventures. Those agreements remain subject to due diligence, licensing and regulatory approvals. Chief Investment Officer Ben Regin said the company expects to regain possession of two Florida properties totaling 593,000 square feet following Parallel’s default on lease obligations. President and Chief Executive Officer Paul Smithers said Innovative Industrial Properties intends to coordinate an orderly transition of possession with Parallel while retaining its rights and remedies under the leases. → 3 Drone Stocks That Should Soar After the Summer Slump Will This New Development Mean A Big Rally In Cannabis Stocks? Management characterized Florida as the country’s largest medical cannabis market, citing its patient base, consumer demand and limited-license structure. Regin said the company is already receiving interest in the two properties and believes the state’s market conditions could support demand for the facilities. Across the executed leases and 4Front-related agreements, the company described approximately 877,000 square feet of gross leasing activity. Regin said estimated average total leasing costs for those assets are expected to be less than $5 per square foot. He also said lease commencement generally takes more than nine to 12 months after execution because of abatement periods and licensing requirements. → Why Rare Earth Processing Could Be the Real 2027 Opportunity During the question-and-answer session, Regin said the company has multiple additional assets under letters of intent and in various stages of negotiation, though timing remains uncertain due to diligence requirements. Management said it hopes to convert some of those discussions into additional leasing activity during the remainder of 2026 and into 2027. Innovative Industrial Properties completed the $88.5 million sale of a 389,000-square-foot New York facility to Vireo Growth under a tenant purchase option. The company received an approximately $39 million down payment and provided roughly $49 million in seller financing carrying a 15% interest rate. The company also sold an undeveloped land site in San Marcos, Texas, and is under contract to sell retail properties in Michigan and California, subject to closing conditions and contingencies. Together with the earlier sale of an Arizona dispensary property, management said the transactions reflect an effort to monetize selected assets and recycle capital. Regin said the San Marcos property had been acquired through a transaction with Parallel and was never developed with cannabis-specific improvements. While management views Texas as a potential opportunity, it determined that redeploying capital into other investments was preferable to waiting through what it viewed as a lengthy development and approval timeline. The company fully funded the remaining $120 million of its $270 million commitment to IQHQ, a life sciences real estate platform. Executive Chairman Alan Gold said the most recent funding was generating a yield of more than 14% and described life sciences investments as a potential source of larger-scale deployment opportunities. IQHQ recently entered a long-term lease with clinical-stage radiopharmaceutical company AdvanCell for the full 128,000-square-foot 1 Corporate Drive building at Innovation Park in Andover, Massachusetts. AdvanCell said the facility is expected to serve as its U.S. manufacturing site and global headquarters. Regin said the AdvanCell lease follows IQHQ’s previously announced 244,000-square-foot lease with Lila Sciences at Alewife Park, representing approximately 372,000 square feet of gross leasing across the two assets since Innovative Industrial Properties made its initial IQHQ investment. Management cited third-party reports from CBRE and JLL indicating improving life sciences leasing activity and venture capital funding, while noting that vacancy remains elevated. Regin said the development pipeline has declined substantially from its 2023 peak and that much of the remaining new supply is pre-leased. During the quarter, Innovative Industrial Properties completed nearly $150 million of secured term loan financings through five transactions. It also raised $35 million through its common-stock at-the-market program and $21 million through its preferred-stock ATM program. The proceeds, along with cash and revolving credit availability, supported repayment of $291 million of notes due in May. In June, the company issued $402.5 million of 6% exchangeable notes due in 2029, after upsizing the offering in response to investor demand. It repurchased approximately $80.5 million of common stock in connection with the transaction and used part of the remaining proceeds to repay revolver borrowings. Smith said the company ended the quarter with $300 million in total liquidity. Net debt to adjusted EBITDA was 1.7 times, and net debt to total gross assets was 14%. Smithers also pointed to continued federal cannabis reform developments, including the completion of a Drug Enforcement Administration hearing on proposed marijuana rescheduling from Schedule I to Schedule III. He said the matter now goes to an administrative law judge for a recommended decision before returning to the DEA for final action. At the state level, Smithers said Virginia established a regulated adult-use retail cannabis market, with sales expected to begin July 1, 2027. He also cited Trulieve’s New York Stock Exchange listing and potential major-exchange listings involving Curaleaf, Verano and Ascend Wellness as signs that cannabis operators could gain broader access to institutional investors and traditional capital sources. Innovative Industrial Properties, Inc is a real estate investment trust (REIT) focused on the acquisition, ownership and management of specialized industrial properties leased to state-licensed operators in the regulated U.S. cannabis industry. The company’s portfolio includes greenhouse facilities, indoor cultivation sites, processing and distribution centers, and other purpose-built properties designed to meet stringent regulatory and operational requirements. By structuring long-term net leases, Innovative Industrial Properties provides its tenants with capital to expand and modernize their operations while maintaining stable, predictable rental income streams. Founded in 2016 and headquartered in San Diego, California, Innovative Industrial Properties was the first publicly traded REIT in the medical-cannabis sector. This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to [email protected]. The article "Innovative Industrial Properties Q2 Earnings Call Highlights" was originally published by MarketBeat. View MarketBeat's top stocks for August 2026.

This article first appeared on GuruFocus. Release Date: August 04, 2026 For the complete transcript of the earnings call, please refer to the full earnings call transcript. Innovative Industrial Properties Inc (NYSE:IIPR) successfully completed the full funding of its $270 million commitment to IQHQ, marking a key milestone in its portfolio diversification strategy. The company executed new leases totaling approximately 389,000 square feet across five properties year-to-date, demonstrating strong leasing execution and driving occupancy. IIPR strengthened its balance sheet by completing $150 million in secured term loans, repaying its $291 million senior debt maturity, and executing an upsized $402.5 million exchangeable notes offering. The company repurchased approximately $80.5 million of its common stock, signaling confidence in its long-term value and enhancing shareholder returns. IIPR completed the sale of its New York facility for $88.5 million, including seller financing at a 15% interest rate, and other dispositions, effectively recycling capital into accretive opportunities. The company reported strong balance sheet metrics with net debt to adjusted EBITDA of 1.7 times and total liquidity of $300 million, providing ample financial flexibility. Federal cannabis reform progressed with the DEA hearing completion, and major operators like Trulieve listed on the NYSE, potentially expanding the industry's access to capital markets. IQHQ's portfolio showed positive momentum with new leases, including a 128,000 square foot lease with AdvancedCell, and improving life science market fundamentals. Innovative Industrial Properties Inc (NYSE:IIPR) experienced a decrease in total revenues to $63.3 million in Q2 2026 from $69 million in Q1, driven by reduced payments from defaulting tenants. The company's AFFO per diluted share declined to $1.83 from $1.88 in the prior quarter, reflecting the impact of tenant defaults. Parallel defaulted on lease obligations at two Florida properties totaling 593,000 square feet, requiring an orderly transition of possession and adding uncertainty to the portfolio. The timing of federal cannabis rescheduling remains uncertain, with the process still awaiting an administrative law judge's recommendation and final DEA action. Leasing activity for new tenants is subject to long timelines, with a 9 to 12+ month period from lease execution to rent commencement, delaying revenue recognition. The company faces ongoing challenges with certain tenants, including PharmaCan assets in New York and Pennsylvania, where resolutions are still being negotiated. Despite progress, the life science sector still has elevated vacancy rates, although the development pipeline has decreased significantly. Warning! GuruFocus has detected 12 Warning Signs with IIPR. Is IIPR fairly valued? Test your thesis with our free DCF calculator. Q: How should we think about deploying the increased liquidity, and are opportunities in life sciences versus legacy cannabis coming in larger or smaller chunks? A: Alan Gold, Executive Chairman, stated that the company is now positioned for growth following strong balance sheet and portfolio execution. The diversification into life sciences is progressing well, with the completed $270 million commitment to IQHQ generating greater than a 14% yield, which is highly accretive. Life science transactions are fairly large, suggesting potential large-scale future investments, but the company is also monitoring an improving cannabis market for growth opportunities. Q: Given the recent Parallel default, how comfortable are you with the current cannabis portfolio, especially with improving industry conditions like 280E tax changes and rescheduling? A: Alan Gold, Executive Chairman, explained that the Parallel situation was a slow-moving restructuring over several years that culminated in the company regaining two high-quality assets in Florida, a strong market already attracting interest. The broader portfolio is strengthening, and the company is monitoring tenants regularly. He expressed optimism that the positive effects of rescheduling will materialize throughout 2026 and into 2027. Q: What changed regarding the sale of the San Marcos, Texas land site, especially as Texas' medical program develops? A: Ben Regan, Chief Investment Officer, clarified that nothing changed in their view of Texas. The site was an undeveloped piece of land from a prior Parallel transaction, and the cannabis-specific improvements were never built. Given the extended runway before development would be needed, they felt recycling that capital into highly accretive transactions like the IQHQ funding was a better use of funds. Q: With changing regulations, whose cost of capital is set to improve more, yours or your tenants'? A: Paul Smithers, President and CEO, said both. Tenants benefit from moves like Trulieve's NYSE listing and similar steps by Curaleaf, Verano, and Ascend, which provide access to public capital markets. IIPR benefits from diversification into life sciences, which makes lenders view them more positively, and their access to capital in the cannabis space should improve with rescheduling. Q: Can you give a sense of what leases commenced in Q2 and what to expect in the second half of the year, given the run-rate revenue seemed stronger than expected? A: Ben Regan, Chief Investment Officer, stated there was nothing material that commenced in Q2. He reiterated that the timeline from lease execution to rent commencement is typically 9 to 12+ months due to abatement periods and licensing. David Smith, CFO, added that Q1 included a $1.5 million payment from Goldflora that may not have been adjusted for, and offered to discuss the numbers further offline. Q: Regarding the PharmaCan assets in New York and Pennsylvania, is there potential for a quicker resolution, and how could it impact occupancy? A: Ben Regan, Chief Investment Officer, said they are pleased with the interest in those two assets. While nothing has changed on the Montgomery asset, they are working towards a potential resolution with new tenants for both properties, which would further stabilize the portfolio on top of the nearly 900,000 square feet already discussed. He couldn't provide more detail at this time. Q: Are there any other assets under LOI that you expect to execute formal leases on in the near term? A: Ben Regan, Chief Investment Officer, confirmed there are multiple assets under LOI in various stages of negotiation. He focused on the executed leases and Forefront agreements totaling nearly a million square feet, and expressed hope to convert additional LOIs into incremental leasing activity through the balance of 2026 and into 2027. Q: How should we think about the impact of the Parallel default on the Florida properties and the potential for re-leasing them? A: Paul Smithers, President and CEO, noted that Florida remains the largest medical cannabis market in the country with strong fundamentals. Ben Regan, Chief Investment Officer, added that they expect to regain possession of the two properties totaling 593,000 square feet and are optimistic that market conditions will translate to meaningful demand for the facilities. Q: Can you provide more detail on the leasing costs associated with the recent re-leasing activity? A: Ben Regan, Chief Investment Officer, stated that based on the approximately 877,000 square feet of gross leasing activity, they estimate average total leasing costs will be less than $5 per square foot, highlighting the capital-efficient manner in which they have been able to retenant properties. Q: What is the status of the IQHQ investment and the broader life sciences market? A: Ben Regan, Chief Investment Officer, confirmed the full funding of the $270 million commitment. IQHQ has announced significant leasing activity, including a lease with AdvancedCell for the entire 128,000 square foot building at Innovation Park. Market data shows improving fundamentals, with leasing activity up, venture capital funding at its highest level since 2022, and the unleased supply pipeline representing less than 1% of total inventory, reinforcing confidence in the sector. For the complete transcript of the earnings call, please refer to the full earnings call transcript.

Significant Liquidity of $300 Million Available to Support Strategic Growth SAN DIEGO, August 03, 2026--(BUSINESS WIRE)--Innovative Industrial Properties, Inc. (NYSE: IIPR) ("IIP" or the "Company") announced today results for the second quarter ended June 30, 2026. Executive Chairman Remarks "Our second quarter activity reflects the continued execution of our strategy across multiple fronts by our management team. We completed the funding of our $270 million investment in IQHQ, generated meaningful leasing momentum across our portfolio and proactively strengthened our balance sheet through a series of successful capital markets transactions," said Alan Gold, Executive Chairman of IIP. "With substantial liquidity, conservative leverage and demonstrated access to multiple sources of capital, we believe we are well positioned to pursue attractive, accretive growth opportunities to deliver long-term value to our shareholders." Second Quarter 2026 Financial Results and Dividend Total revenues of $63.3 million and net income attributable to common stockholders of $40.7 million, or $1.36 per diluted share (all per share amounts in this press release are reported on a diluted basis unless otherwise noted). Adjusted funds from operations ("AFFO") of $53.0 million, or $1.83 per share Declared dividends to common stockholders totaling $1.90 per share. Since its inception, IIP has paid over $1.2 billion in common stock dividends to its stockholders. Completed an upsized private offering of $402.5 million aggregate principal amount of 6.0% exchangeable senior notes due 2029 (the "Exchangeable Notes"). IQHQ Investment Funded $120.0 million of Series G preferred equity during the second quarter. As of June 30, 2026, the Company had fully funded an aggregate of $270.0 million of its strategic investment in IQHQ, Inc., consisting of a $100.0 million revolving credit facility and $170.0 million of Series G preferred equity. Portfolio - Leasing and Dispositions In April 2026, executed a 58,000 square foot full-building lease in Buckeye Lake, Ohio with Curaleaf, a public multi-state operator. In May 2026, the Company sold a land parcel located in San Marcos, Texas for approximately $3.3 million in gross proceeds. The Company recorded a loss on sale of $4.9 million in connection with the transaction. In May 2026, the Company sold a property located in Perth, New York for $88.5 million pursuant to a tenant purchase option and provided $49.0 million of seller financing. The Company recorded a gain on sale of $16.7 million in connection with the transaction. Portfolio - Select Tenant Updates The following table summarizes payments received from certain defaulted tenants during the periods presented and the corresponding per share impact (in thousands, except per share amounts): PharmaCann 4Front Balance Sheet Highlights (at June 30, 2026) 14.2% net debt to total gross assets, with $3.0 billion in total gross assets. Total liquidity was $299.7 million, consisting of cash and cash equivalents (as reported in IIP’s consolidated balance sheet as of June 30, 2026) and availability under IIP’s revolving credit facilities. Net Debt to Adjusted EBITDA of 1.7x. Financing Activity Preferred Stock Common Stock Note Repayment Exchangeable Notes Secured Debt Financial Results For the three months ended June 30, 2026, IIP generated total revenues of $63.3 million, compared to $62.9 million for the same period in 2025, an increase of 0.7%. The modest increase was primarily attributable to new leases executed on existing properties and annual contractual rent escalations on certain properties, which were substantially offset by decreases in rental revenue resulting from the sale of certain properties, tenant defaults and lease terminations. For the three months ended June 30, 2026, the Company applied $1.2 million of security deposits for payment of rent on properties leased to Battle Green and The Cannabist Company. During the three months ended June 30, 2025, the Company applied $18,000 of security deposits for payment of rent on a property leased to Emerald Growth, which was sold in April 2025. For the three months ended June 30, 2026, interest and other income increased by $9.2 million to $10.8 million compared to $1.6 million for the three months ended June 30, 2025. The increase was primarily driven by the recognition of $8.5 million of interest and dividend income related to our financial investments in IQHQ, as well as interest income recognized on the seller-financed note associated with the sale of a property in Perth, New York. Dividend On June 15, 2026, the Board of Directors declared a second quarter 2026 dividend of $1.90 per common share, representing an annualized dividend of $7.60 per common share. The dividend was paid on July 15, 2026 to stockholders of record as of June 30, 2026. Supplemental Information Supplemental financial information is available in the Investor Relations section of IIP’s website at www.innovativeindustrialproperties.com. Teleconference and Webcast The Company will conduct a conference call and webcast at 9:00 a.m. Pacific Time (12:00 p.m. Eastern Time) on Tuesday, August 4, 2026 to discuss IIP’s financial results and operations for the second quarter ended June 30, 2026. The call will be open to all interested investors through a live audio webcast at the Investor Relations section of IIP’s website at www.innovativeindustrialproperties.com, or live by calling 1-833-461-5787 (domestic) or 1-585-542-9983 (international) and asking to be joined to the Innovative Industrial Properties, Inc. conference call using meeting ID 557683068. The complete webcast will be archived for one year on IIP’s website. The website replay will be posted in the Investor Relations section of innovativeindustrialproperties.com. About Innovative Industrial Properties Innovative Industrial Properties, Inc. is a real estate investment trust (REIT) focused on the acquisition, ownership and management of specialized industrial properties and life science real estate. Additional information is available at www.innovativeindustrialproperties.com. This press release contains statements that IIP believes to be "forward-looking statements" within the meaning of the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. All statements other than historical facts are forward-looking statements. When used in this press release, words such as IIP "expects," "intends," "plans," "estimates," "anticipates," "believes" or "should" or the negative thereof or similar terminology are generally intended to identify forward-looking statements. Forward-looking statements in this press release include, but are not limited to, statements regarding potential transactions, including proposed leases of our properties, the consummation and timing of which remain subject to the negotiation and execution of definitive documentation, satisfaction of customary closing conditions and other contingencies, including those related to receivership sale processes; the anticipated timing, outcome and effects of pending receivership proceedings, including the effectiveness of arrangements with prospective new tenants for certain properties following the conclusion of such proceedings; the expected transfer of existing cannabis licenses for certain properties to new tenants; and the intended use of net proceeds from the offering of Exchangeable Notes. Such forward-looking statements are subject to risks and uncertainties that could cause actual results to differ materially from those expressed in, or implied by, such statements. You should not rely on forward-looking statements since they involve known and unknown risks, uncertainties and other factors that are, in some cases, beyond the Company's control and which could materially affect actual results, performances or achievements. Factors that may cause actual results to differ materially from current expectations include, but are not limited to, the risk factors discussed in the Company's most recent Annual Report on Form 10-K for the year ended December 31, 2025, as updated by the Company’s subsequent reports filed with the Securities and Exchange Commission. Accordingly, there is no assurance that the Company's expectations will be realized. IIP disclaims any obligation to update or revise any forward-looking statements, whether as a result of new information, future events or otherwise, except as required by federal securities laws. Non-GAAP Financial Measures Funds From Operations (FFO) FFO and FFO per share are operating performance measures adopted by the National Association of Real Estate Investment Trusts, Inc. (NAREIT). NAREIT defines FFO as the most commonly accepted and reported measure of a REIT’s operating performance equal to net income, computed in accordance with accounting principles generally accepted in the United States (GAAP), excluding gains (or losses) from sales of property, depreciation, amortization and impairment related to real estate properties, and after adjustments for unconsolidated partnerships and joint ventures. IIP also excludes from FFO any disposition-contingent lease termination fee received in connection with a property sale. Management believes that net income, as defined by GAAP, is the most appropriate earnings measurement. However, management believes FFO and FFO per share to be supplemental measures of a REIT’s performance because they provide an understanding of the operating performance of IIP's properties without giving effect to certain significant non-cash items, primarily depreciation expense. Historical cost accounting for real estate assets in accordance with GAAP assumes that the value of real estate assets diminishes predictably over time. However, real estate values instead have historically risen or fallen with market conditions. IIP believes that by excluding the effect of depreciation, FFO and FFO per share can facilitate comparisons of operating performance between periods. IIP reports FFO and FFO per share because these measures are observed by management to also be the predominant measures used by the REIT industry and by industry analysts to evaluate REITs and because FFO per share is consistently reported, discussed, and compared by research analysts in their notes and publications about REITs. For these reasons, management has deemed it appropriate to disclose and discuss FFO and FFO per share. The Exchangeable Notes were dilutive for purposes of calculating earnings per diluted share for the three and six months ended June 30, 2026, as GAAP requires convertible notes that can be settled in cash and/or shares at the Company’s discretion to be evaluated under the if-converted method. However, for the purposes of calculating FFO, Normalized FFO and AFFO per diluted share, the Company excludes the dilutive impact of the Exchangeable Notes under the if-converted method as management believes the evaluation of operating performance based on actual diluted shares outstanding is more appropriate to facilitate consistent comparisons between reporting periods and reflects the actual shares that are entitled to common stock dividends each period. Accordingly, for the three months ended June 30, 2026, cash interest expense of $1.0 million relating to the Exchangeable Notes was included and 1,019,877 weighted-average shares potentially issuable upon exchange of the Exchangeable Notes under the if-converted method were excluded from the calculation of FFO, Normalized FFO and AFFO per diluted share. For the six months ended June 30, 2026, cash interest expense of $1.0 million relating to the Exchangeable Notes was included and 512,756 weighted-average shares potentially issuable upon exchange of the Exchangeable Notes under the if-converted method were excluded from the calculation of FFO, Normalized FFO and AFFO per diluted share. Normalized Funds from Operations (Normalized FFO) IIP computes Normalized FFO by adjusting FFO, as defined by NAREIT, to exclude certain GAAP income and expense amounts that management believes are infrequent and unusual in nature and/or not related to IIP's core real estate operations. Exclusion of these items from similar FFO-type metrics is common within the equity REIT industry, and management believes that presentation of Normalized FFO and Normalized FFO per share provides investors with a metric to assist in their evaluation of IIP's operating performance across multiple periods and in comparison to the operating performance of other companies, because it removes the effect of unusual items that are not expected to impact IIP's operating performance on an ongoing basis. Normalized FFO is used by management in evaluating the performance of IIP's core business operations. Adjusted Funds from Operations (AFFO) Management believes that AFFO and AFFO per share are also appropriate supplemental measures of a REIT’s operating performance. IIP calculates AFFO by adjusting Normalized FFO for certain non-cash items. IIP’s computation of FFO, Normalized FFO and AFFO may differ from the methodology for calculating FFO, Normalized FFO and AFFO utilized by other equity REITs and, accordingly, may not be comparable to such REITs. Further, FFO, Normalized FFO and AFFO do not represent cash flow available for management’s discretionary use. FFO, Normalized FFO and AFFO should not be considered as an alternative to net income (computed in accordance with GAAP) as an indicator of IIP’s financial performance or to cash flow from operating activities (computed in accordance with GAAP) as an indicator of IIP’s liquidity, nor is it indicative of funds available to fund IIP’s cash needs, including IIP’s ability to pay dividends or make distributions. FFO, Normalized FFO and AFFO should be considered only as supplements to net income computed in accordance with GAAP as measures of IIP’s operations. Definitions EBITDA and Adjusted EBITDA: EBITDA is defined as earnings (net income per income statement) before interest expense, income taxes, depreciation and amortization (including above-market lease amortization and corporate asset deprecation) and non-cash accretion of life science investments. Adjusted EBITDA is EBITDA adjusted for non-cash stock-based compensation, gain (loss) on sale of real estate, impairment loss on real estate, income on seller-financed notes and deferred lease payments received on sales-type lease. Management believes EBITDA and Adjusted EBITDA are meaningful supplemental measures of a REIT’s performance because they provide additional information regarding our operating performance without giving effect to certain financing decisions, tax considerations and significant non-cash items. Adjusted EBITDA further excludes certain items that management does not consider representative of IIP's ongoing operating performance or that may vary significantly between periods, and includes certain cash receipts not included in EBITDA. Management believes these measures facilitate comparisons of IIP's operating performance between periods and with other REITs. In addition, EBITDA and Adjusted EBITDA is widely followed by industry analysts, lenders, investors, rating agencies, and others as a means of evaluating the operational cash generating capacity of a company prior to servicing debt obligations. For these reasons, management has deemed it appropriate to disclose and discuss EBITDA and Adjusted EBITDA. Net Debt: Calculated as the sum of the outstanding principal balance of the Exchangeable Notes, term loans, and the Revolving Credit Facilities, less cash and cash equivalents, as presented on IIP's consolidated balance sheet as of June 30, 2026. Gross Assets: Calculated as total assets plus accumulated depreciation, as presented on IIP's consolidated balance sheet as of June 30, 2026. View source version on businesswire.com: https://www.businesswire.com/news/home/20260802769895/en/ Contacts Company Contact:David SmithChief Financial OfficerInnovative Industrial Properties, Inc.(858) 997-3332

SAN DIEGO, June 15, 2026--(BUSINESS WIRE)--Innovative Industrial Properties, Inc. (NYSE: IIPR) ("IIP" or the "Company") announced today that its board of directors has declared a second quarter 2026 dividend of $1.90 per share of common stock, representing an annualized dividend of $7.60 per common share. Since its inception in 2016, the Company has paid $1.2 billion in common stock dividends to its shareholders. Additionally, IIP announced today that its board of directors has declared a regular quarterly dividend of $0.5625 per share of IIP’s 9.00% Series A Cumulative Redeemable Preferred Stock. The dividends are payable on July 15, 2026 to stockholders of record at the close of business on June 30, 2026. About Innovative Industrial Properties Innovative Industrial Properties, Inc. is a real estate investment trust (REIT) focused on the acquisition, ownership and management of specialized industrial properties and life science real estate. Additional information is available at www.innovativeindustrialproperties.com. This press release contains statements that IIP believes to be "forward-looking statements" within the meaning of the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. All statements other than historical facts are forward-looking statements. When used in this press release, words such as IIP "expects," "intends," "plans," "estimates," "anticipates," "believes" or "should" or the negative thereof or similar terminology are generally intended to identify forward-looking statements. Forward-looking statements include discussions of the amount, growth, timing and payment of dividends. Such forward-looking statements are subject to risks and uncertainties that could cause actual results to differ materially from those expressed in, or implied by, such statements. Factors that may cause actual results to differ materially from current expectations include, but are not limited to, the risk factors discussed in the Company’s annual report on Form 10-K for the year ended December 31, 2025. Investors should not place undue reliance upon forward-looking statements. IIP disclaims any obligation to update or revise any forward-looking statements, whether as a result of new information, future events or otherwise. View source version on businesswire.com: https://www.businesswire.com/news/home/20260615317875/en/ Contacts IIP Contact:David SmithChief Financial OfficerInnovative Industrial Properties, Inc.(858) 997-3332

A month has gone by since the last earnings report for Innovative Industrial Properties (IIPR). Shares have lost about 3.9% in that time frame, underperforming the S&P 500. But investors have to be wondering, will the recent negative trend continue leading up to its next earnings release, or is Innovative Industrial Properties due for a breakout? Well, first let's take a quick look at its most recent earnings report in order to get a better handle on the recent catalysts for Innovative Industrial Properties, Inc. before we dive into how investors and analysts have reacted as of late. Innovative Industrial Properties posted first-quarter 2026 AFFO of $1.88 per share, edging past the Zacks Consensus Estimate of $1.87. Total revenues came in at $69.0 million, topping the consensus mark by 3.1%. Results reflected steady leasing execution and a meaningful lift from interest and dividend income tied to the company’s IQHQ life science investment, even as revenues and FFO slipped year over year. Executed leases totaled 389,000 square feet year to date, supporting portfolio occupancy. Management emphasized leasing traction early in 2026. In January, the company executed a 204,000-square-foot full-building lease in Desert Hot Springs, CA, with Gramlin. It also executed a 5,000-square-foot lease in Palm Springs, CA, and a 56,000-square-foot full-building lease in Palm Springs with Gramlin, along with a 66,000-square-foot full-building lease in Dwight, IL, with Grown Rogue. The operating portfolio was 97.8% leased as of March 31, 2026, highlighting that re-tenanting progress has helped preserve utilization levels, even as certain tenants have remained under stress. The portfolio stood at 110 properties across 19 states and approximately 8.9 million rentable square feet. A major swing factor in the quarter was interest and other income, which rose to $6.3 million from $1.6 million in the first quarter of 2025. The company tied the increase largely to recognizing $5.5 million of interest and dividend income related to its financial investments in IQHQ. As of March 31, 2026, Innovative Industrial funded $150 million of its strategic IQHQ investment, comprising a fully funded $100 million revolving credit facility and $50 million of Series G preferred equity. After quarter-end, it funded an additional $25 million of Series G preferred equity and reiterated a remaining commitment of up to $95 million through second-quarter 2027. Total revenues of $69 million declined 3.8% from $71.7 million in the year-ago quarter, with management attributing the drop primarily to tenant defaults. Those pressures were partly offset by contractual rent escalations, revenues from a property acquired in February 2025 and new leases on existing assets. Rental revenues (including tenant reimbursements) were $68.9 million versus $71.7 million a year ago, while “other” revenues were minimal. The year-over-year revenue contraction underscores that cash collections and re-tenanting progress remain key variables for near-term growth. On the expense line, property expenses increased to $7.6 million from $7.4 million in the prior-year quarter. General and administrative expenses moved higher to $10.3 million from $8.5 million. The top 10 tenants accounted for roughly 91.5% of annualized base rent, with PharmaCann and 4Front noted as in default. Innovative Industrial exited the quarter with total assets of $2.39 billion, including $2.09 billion of net real estate held for investment and $154.0 million of life science investments. Cash and cash equivalents were $89.1 million. Leverage metrics remained conservative. The company reported 13% debt to total gross assets and total liquidity of $176.6 million, consisting of cash and revolver availability. Management also highlighted ongoing balance sheet actions, including equity issuance so far in the year and additional debt financings underway to address the upcoming bond maturity. In the past month, investors have witnessed a downward trend in estimates revision. At this time, Innovative Industrial Properties has a subpar Growth Score of D, a grade with the same score on the momentum front. However, the stock has a grade of B on the value side, putting it in the second quintile for value investors. Overall, the stock has an aggregate VGM Score of D. If you aren't focused on one strategy, this score is the one you should be interested in. Estimates have been broadly trending downward for the stock, and the magnitude of this revision indicates a downward shift. It's no surprise Innovative Industrial Properties has a Zacks Rank #4 (Sell). We expect a below average return from the stock in the next few months. Innovative Industrial Properties is part of the Zacks REIT and Equity Trust - Other industry. Over the past month, Crown Castle (CCI), a stock from the same industry, has gained 0.9%. The company reported its results for the quarter ended March 2026 more than a month ago. Crown Castle reported revenues of $1.01 billion in the last reported quarter, representing a year-over-year change of -4.8%. EPS of $0.50 for the same period compares with $1.10 a year ago. For the current quarter, Crown Castle is expected to post earnings of $1.00 per share, indicating a change of -2% from the year-ago quarter. The Zacks Consensus Estimate remained unchanged over the last 30 days. Crown Castle has a Zacks Rank #3 (Hold) based on the overall direction and magnitude of estimate revisions. Additionally, the stock has a VGM Score of D. Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report Innovative Industrial Properties, Inc. (IIPR) : Free Stock Analysis Report Crown Castle Inc. (CCI) : Free Stock Analysis Report This article originally published on Zacks Investment Research (zacks.com). Zacks Investment Research

Interested in Innovative Industrial Properties, Inc.? Here are five stocks we like better. Innovative Industrial Properties reported Q1 2026 revenue of $69 million and AFFO of $53.4 million, or $1.88 per share, with results roughly in line with the prior quarter. Management said revenue improved on tenant payments and settlement receipts. The company is actively shoring up its balance sheet ahead of a near-term bond maturity, having raised $128 million year to date through preferred equity, common equity and secured debt. It also said total liquidity was about $177 million and additional financing transactions are under discussion. Executives highlighted federal cannabis rescheduling as a major industry development, saying Schedule III could remove the burden of Section 280E for qualifying medical operators. At the same time, they stressed that key issues like interstate commerce and banking access remain unresolved. This 4/20, Wall Street Is Betting on More Than Marijuana Innovative Industrial Properties (NYSE:IIPR) reported first-quarter 2026 revenue of $69 million and adjusted funds from operations of $53.4 million, or $1.88 per share, as executives said the company is working to stabilize its cannabis real estate portfolio, refinance a near-term bond maturity and position itself for growth amid changes in federal cannabis policy. Executive Chairman Alan Gold said the quarter represented “a strong start to the year,” citing leasing progress and recent capital-raising activity. He said persistent inflation, elevated interest rates and broader macroeconomic headwinds continued to challenge the operating environment, but added that the company has focused on portfolio optimization, disciplined capital allocation and maintaining balance sheet flexibility. → Beyond NVIDIA: Picks-and-Shovels AI Plays with Strong Momentum The only 2 cannabis companies you need to own “We have been active on the debt and equity capital raising front, raising $128 million of gross proceeds year to date,” Gold said. He added that the company was working on several additional secured and unsecured financing transactions totaling nearly $130 million, including a $56.5 million financing at an 8.75% rate that the company expected to fund that day. Chief Financial Officer David Smith said first-quarter revenue rose 3.5% from the fourth quarter, primarily due to $3.2 million of payments received from PharmaCann. He also noted the company received $1.5 million during the quarter in settlement of remaining unpaid administrative rents due from the Gold Flora receivership. → 3 Ways to Target the Resources Powering AI and Data Centers Will This New Development Mean A Big Rally In Cannabis Stocks? AFFO of $53.4 million, or $1.88 per share, was in line with the fourth quarter of 2025, according to Smith. Smith said addressing the company’s bond maturity this month has been “a key focus.” Year to date, Innovative Industrial Properties raised $128 million of gross capital, consisting of $72 million of preferred equity, $36 million of common equity and $20 million of secured debt through a recently closed three-year secured term loan with a fixed rate of 9%. → Quantum Earnings Season Is Ramping Up—What to Watch From 2 Major Players Smith said the additional financings under discussion would carry a blended rate of just over 8%, based on current terms, though he cautioned that the transactions remain subject to contingencies and may not be completed on the terms contemplated or at all. As of March 31, the company had total liquidity of approximately $177 million, including $89 million of cash and $87.5 million of availability under revolving credit facilities. Smith said the company’s debt service coverage ratio exceeded 11 times, while net debt to adjusted EBITDA was 1.1 times. Gold and President and CEO Paul Smithers emphasized federal cannabis policy developments as a key topic for the company and its tenants. Gold said the administration’s recent action regarding the medical cannabis market represented “a major milestone for the industry” and “a clear sign of continued progress at the federal level.” Smithers said the Department of Justice and acting attorney general issued a final order moving FDA-approved cannabis products and cannabis produced by state-licensed medical operators to Schedule III. He called it “the most significant development affecting our business since our founding in 2016.” According to Smithers, the action eliminates the burden of Section 280E for qualifying medical operators, may create an opportunity for retrospective tax relief and establishes an expedited DEA registration process for medical operators. He also said the DEA restarted the broader hearing process on whether marijuana as a category should move to Schedule III, with hearings set to begin June 29 under an expedited timeline. In response to analyst questions, Smithers said the DOJ order currently applies to licensed medical-use operators and that all of the company’s operators hold medical licenses. He said the order requested Treasury guidance on the retroactive effect of Section 280E for medical and adult-use businesses. Smithers also said rescheduling does not address interstate commerce, banking or up-listing, and he does not expect interstate commerce until broader legalization, which he said the company believes is “many years out.” The company said it signed new leases at four properties totaling approximately 331,000 square feet during the quarter. Chief Investment Officer Ben Regin said that year to date, Innovative Industrial Properties executed new leases totaling 389,000 square feet across five properties in California, Illinois and Ohio, and completed the sale of a dispensary in Arizona. Regin said the company has made progress stabilizing assets tied to former tenant issues involving Gold Flora, PharmaCann and 4Front. All three former Gold Flora properties, totaling 330,000 square feet, are now leased. Those include a 70,000-square-foot Palm Springs property leased in November 2025, a 204,000-square-foot Desert Hot Springs property leased in January 2026 and a 56,000-square-foot Palm Springs property leased in March 2026. For former 4Front properties, Regin said the company has reached tentative agreements with prospective new tenants for all four properties, representing approximately 488,000 square feet across Illinois, Washington and Massachusetts. Those agreements remain subject to diligence and licensing approvals and are expected to take effect after receivership proceedings conclude, which the company currently expects later this year. For former PharmaCann assets, Regin said the company executed a March lease for a 66,000-square-foot property in Dwight, Illinois, with Grown Rogue, a publicly traded multistate operator new to the company’s tenant roster. In April, it executed a lease for a 58,000-square-foot Ohio property with Curaleaf, a public multistate operator and longtime tenant partner. Regin said the company also executed a non-binding letter of intent for a 234,000-square-foot facility in New York and is negotiating leases for other assets, including a 71,000-square-foot property in North Adams, Massachusetts, and a 270,000-square-foot property in Pennsylvania where it regained possession on April 15. He cautioned that there is no assurance those talks will lead to definitive leases. The company’s 157,000-square-foot property in Columbus, Ohio, remains leased to Battle Green, which Regin said defaulted on its lease obligations in March. He said the company is enforcing its rights, including eviction proceedings and remedies under applicable guarantees. Gold said the company continues to view its investment in IQHQ as a “compelling strategic opportunity” and an extension of its platform. The company has funded $175 million of its $270 million commitment, with $95 million remaining to be funded over time. Regin said the life science real estate market is showing signs of stabilization and improving momentum in 2026, citing recent reports from CBRE and Colliers that indicate demand has held near pre-pandemic levels while equity performance and venture funding support a more constructive growth backdrop. He also said elevated vacancy from prior supply remains a factor, but new development has fallen sharply and the pipeline is at historically low levels. Asked about the potential balance between cannabis and life science over the next several years, Gold said it was difficult to answer, but said the company is positioned to be opportunistic in “two growing industries” that may support shareholder growth. Innovative Industrial Properties, Inc is a real estate investment trust (REIT) focused on the acquisition, ownership and management of specialized industrial properties leased to state-licensed operators in the regulated U.S. cannabis industry. The company’s portfolio includes greenhouse facilities, indoor cultivation sites, processing and distribution centers, and other purpose-built properties designed to meet stringent regulatory and operational requirements. By structuring long-term net leases, Innovative Industrial Properties provides its tenants with capital to expand and modernize their operations while maintaining stable, predictable rental income streams. Founded in 2016 and headquartered in San Diego, California, Innovative Industrial Properties was the first publicly traded REIT in the medical-cannabis sector. This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to [email protected]. The article "Innovative Industrial Properties Q1 Earnings Call Highlights" was originally published by MarketBeat. View MarketBeat's top stocks for May 2026.

Management views the DOJ's final order moving medical cannabis to Schedule III as the most significant regulatory milestone since the company's 2016 inception. Performance was driven by disciplined capital allocation and aggressive leasing activity, successfully addressing over 90% of assets previously impacted by tenant defaults. The company is leveraging a dual-platform strategy, utilizing its life science investment in IQHQ as a counter-cyclical hedge and growth extension alongside its core cannabis portfolio. Operational stability was bolstered by resolving litigation with PharmaCann and securing new leases with established multistate operators like Curaleaf and Grown Rogue. Management attributes the current growth trajectory to a 'resurging' life science sector and a strengthening cannabis industry environment following federal rescheduling actions. Strategic positioning focuses on high-quality, mission-critical facilities that maintain demand despite broader macroeconomic headwinds like inflation and elevated interest rates. The primary near-term priority is completing the refinancing of unsecured debt maturities using proceeds from approximately $130 million in pending financing transactions. Management expects the rescheduling of cannabis to act as a powerful catalyst for improving operator economics by eliminating the 280E tax burden for medical operators. Capital allocation remains focused on driving performance in the existing portfolio, pursuing attractive cannabis opportunities for growth in the second half of 2026, and fulfilling the remaining $95 million of the $270 million commitment to IQHQ. The company anticipates increased demand for expansion capital from tenants as they reinvest tax savings from potential 280E relief into growth initiatives. Guidance for portfolio performance assumes the successful transition of triple-net expenses to new tenants upon the commencement of recently signed leases. The company regained possession of a 270,000 square foot Pennsylvania property on April 15 and is currently seeking a replacement tenant. Battle Green defaulted on lease obligations for a 157,000 square foot Ohio facility in March; management is currently pursuing eviction and guarantee remedies. Revenue for the quarter included $3.2 million in payments from PharmaCann and a $1.5 million settlement from the Gold Flora receivership. Management flagged that while medical cannabis is now Schedule III, adult-use remains under an expedited 30-day review process starting June 29. Our analysts just identified a stock with the potential to be the next Nvidia. Tell us how you invest and we'll show you why it's our #1 pick. Tap here. Management noted that while lease commencement typically takes 3 to 18 months due to licensing transfers, triple-net expenses usually transfer to tenants immediately upon execution. Re-tenanting costs have been minimal, averaging $5 to $10 per square foot, with some 'as-is' deals requiring no capital outlay. Paul Smithers clarified that while 280E relief significantly improves operating cash flow, it does not eliminate standard business risks or the need for effective management. The DOJ order suggests potential for retroactive tax relief for qualifying medical operators, which covers 100% of the current tenant portfolio. Management does not believe rescheduling addresses interstate commerce and views full federal legalization as being 'many years out.' The company's indoor, highly specialized medical cultivation assets are considered well-positioned even if interstate commerce eventually occurs. A potential federal ban on intoxicating hemp is viewed as a positive for the industry as it would remove unregulated competition from 'Delta 8' products. One stock. Nvidia-level potential. 30M+ investors trust Moby to find it first. Get the pick. Tap here.